Recent Research

Stay up-to-date on the advancing field of HCT with short summaries and links to the most relevant published research.

Mailankody S, et al. – A novel research study published in Nature Medicine reviewed the safety and feasibility of allogeneic chimeric antigen receptor (CAR) T-cell therapy in relapsed/refractory multiple myeloma patients. Results showed more than half of the patients responded to treatment despite expected adverse events, showing promise as a safe and effective option for patients with aggressive disease.

Subscribe to E-News

Receive new research summaries monthly.